KPF
RPTP

K2 Principal Fund’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

K2 Principal Fund’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-10,000
Closed -$90K – 404
2016
Q3 		$90K Buy
+10,000
New +$71.1K 0.01% 267

K2 Principal Fund's RPTP Position: Q4 2016 in Review

K2 Principal Fund sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 10,000 shares — an estimated $90K sold.

K2 Principal Fund first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $90K in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • K2 Principal Fund reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • K2 Principal Fund sold 10,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $90K.
  • K2 Principal Fund first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2016 and held it in 1 quarter.
  • K2 Principal Fund's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $90K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on K2 Principal Fund's 13F filing for Q4 2016, filed 15 Feb 2017.